Veronika von Messling
Président chez Helmholtz-Zentrum für Infektionsforschung GmbH
Profil
Veronika von Messling is associated with three organizations, namely German Cancer Research Center, Helmholtz-Zentrum für Infektionsforschung GmbH, and.
Helmholtz Zentrum München Deutsches Forschungszentrum.
She holds the position of Chairman-Supervisory Board in the latter two organizations.
Postes actifs de Veronika von Messling
| Sociétés | Poste | Début |
|---|---|---|
Helmholtz-Zentrum für Infektionsforschung GmbH
 Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Président | - |
Helmholtz Zentrum München Deutsches Forschungszentrum
 Helmholtz Zentrum München Deutsches Forschungszentrum Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München Deutsches Forschungszentrum engages in the operation of a research institution for environmental health. Its activities include research focusing on the interaction of genetics, environmental factors, and lifestyle as well as the development of strategies and applications for the diagnosis, treatment, and prevention of serious common diseases. The company was founded in 1960 and is headquartered in Neuherberg, Germany. | Président | - |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Président | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Helmholtz-Zentrum für Infektionsforschung GmbH
Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Health Technology |
Helmholtz Zentrum München Deutsches Forschungszentrum
Helmholtz Zentrum München Deutsches Forschungszentrum Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München Deutsches Forschungszentrum engages in the operation of a research institution for environmental health. Its activities include research focusing on the interaction of genetics, environmental factors, and lifestyle as well as the development of strategies and applications for the diagnosis, treatment, and prevention of serious common diseases. The company was founded in 1960 and is headquartered in Neuherberg, Germany. | Commercial Services |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
